Gambling disorder is the first behavioral addiction formally recognized in DSM-5 — moved from "Impulse Control Disorders" to "Substance-Related and Addictive Disorders" in 2013 based on accumulating evidence that gambling produces the same reward-circuit reorganization, compulsive engagement, and harmful consequences as substance addictions, without the substance.
DSM-5 criteria: persistent and recurrent problematic gambling behavior with at least 4 of 9 criteria over 12 months: needing increasing amounts to achieve excitement (tolerance); restlessness/irritability when trying to cut down (withdrawal-like); repeated unsuccessful efforts to control; preoccupation with gambling; gambling when distressed; chasing losses; lying about gambling extent; jeopardizing significant relationships or opportunities; relying on others to relieve financial situations caused by gambling.
The neuroanatomy parallels substance use disorders. Gambling activates the VTA-to-nucleus accumbens dopamine pathway with intensity and pattern resembling stimulant use disorder. Variable-ratio reinforcement (gambling's payoff schedule) is particularly powerful at driving compulsive engagement — far more reinforcing than predictable rewards. Reduced prefrontal regulation, distorted decision-making (gambler's fallacy, hot hand fallacy, illusion of control), and reorganization of reward sensitivity all mirror substance addiction patterns.
Demographics and risk: roughly 1-2% of adults meet criteria for gambling disorder lifetime; rates higher in problem gambling without full disorder. Male predominance overall but the gender gap is narrowing. Rates dramatically elevated in patients with bipolar disorder (consider mania as a precipitant), substance use disorders (often co-occurring), Parkinson's disease on dopamine agonists (well-documented impulse control disorder side effect of pramipexole, ropinirole). Online and sports betting growth has increased accessibility and may be increasing prevalence.
Treatment:
Cognitive-behavioral therapy specifically designed for gambling disorder is the most evidence-based intervention. Addresses gambling-specific cognitive distortions, develops alternative behaviors, builds financial recovery planning, addresses comorbid conditions.
Naltrexone (off-label) has the most pharmacologic evidence — likely through reducing reward signaling. Doses 50-150 mg daily, often higher than for alcohol use disorder.
Gamblers Anonymous and other 12-step approaches help many patients.
SSRIs when comorbid mood/anxiety conditions contribute.
Address financial damage — credit counseling, family financial separation in severe cases, sometimes legal intervention. Financial recovery is often the longest part of treatment.
Special situation: dopamine agonist-induced gambling. Pramipexole and ropinirole prescribed for Parkinson's disease or restless legs syndrome can produce impulse control disorders including pathological gambling. Discontinuing or switching the medication often resolves the gambling — this is reversible iatrogenic disease.
When you encounter a patient with gambling disorder, the framework matches substance addiction. Treatment is real and effective. Many patients have hidden the extent of their gambling for years and present in crisis (financial collapse, relationship rupture, legal problems). The crisis often becomes the access point to treatment.